Our Purpose
At Algae-C we strive to redesign the traditional approach of producing ingredients. At the core of our research and technology platform is our desire to improve people’s wellbeing while having a positive impact on the planet and its natural ecosystems.
Overview
Algae-C is a biotechnology company headquartered in Ontario, Canada. Algae-C has perfected its plant-based ingredient production platform working in collaboration with some of Canada’s top research institutions.
Today, Algae-C has brought together one of the largest algae biosynthetics teams from around the world, in addition to multiple key strategic partnerships to succeed in the market.
Our success is the result of valuable partnerships with Universities, research institutes, and industry partners across Canada.
Management Team
Dr. Mather Carscallen
CEO
Ph.D. in Computational Biology and globally recognized for his work in the algae sector. Dr. Carscallen has over 15 years of experience scaling algae production in multiple countries and across numerous sectors, including biofuels, agriculture, and aquaculture.
Andrew Nichols
President
Previously President/Chief Revenue Officer for BioSteel Sports Nutrition (acquired by Canopy Growth (TSX: WEED) and Managing Director of Crocs Canada where he reduced SG&A’s by 30%, and grew it to a $46M P&L.
Alexandra Orozco, MBA
CMO
Over 15 years experience building and leading startups in life sciences with a focus on strategic marketing. Alexandra helped build Ascenta Health Ltd., which was acquired by Nature’s Way of Canada in 2015.
Directors and Advisors
Dr. Mather Carscallen
Pharmaceutical/APIs
Ph.D. in Computational Biology and globally recognized for his work in the algae sector. Dr. Carscallen has over 15 years of experience scaling algae production in multiple countries and across numerous sectors, including biofuels, agriculture, and aquaculture.
Barry Fishman
Pharmaceuticals
Former CEO Teva Pharmaceuticals, Taro Canada, Merus Labs (TSX: MSL) and VIVO Cannabis (TSX: VIVO). M&A experience – IPO: Bedrocan, Mergers: Bedrocan and Tweed, Sales: Merus to Norgine, Acquisitions: Harvest Med. and Canna Farms.
Dr. Catalina Lopez-Correa
Genomics and R&D
Over 20 years experience in research and innovation in biotech and pharma. Expertise in precision medicine, genomics, international development, technology and innovation fields. Benckiser (LON: RKT).
Roar Askhein
Finance
Proven track record of creating significant shareholder value. Deep experience advising companies from start-ups to publicly traded, including key role in sales of Ascenta Health and Ocean Nutrition Canada.
Dave Shekhter
Business Development and Sales Strategy
Over 15 years of business consulting, negotiations, and project management. Founded and exited Cannmart (acquired by Namaste Tech.) and Famous Brandz, among others.
Dr. Pere Paton
Pharmaceutical/APIs
Chief Quality, Technical and Operations Officer at Centrient Pharmaceticals. Dr. Pere holds a PhD in Chemical Engineering and has over 20 years experience as a senior executive in the API business in a GMP environment.
Sharon James
Pharma/Strategy
Senior Advisor for Bain & company. Director for Novozyme (CPH: NZYM B) and Molnlycke Health Care. Former EVP of Global R&D for Bayer (NASDAQ: BAYRY). Former Senior VP of Global R&D for Reckitt Benckiser (LON: RKT).
Dr. Craig Behnke
Drug Discovery
EVP, Production and Development, Lumen Bioscience and Former VP, Business Development, Sapphire Energy. PhD in Biochemistry with over 16 years of experience in commercial biotechnology.
Leslie Ewing
Consumer Products
Executive Director, Plant-Based Foods of Canada. 25 years of managing multi-stakeholder projects with the consumer products industry liaising with Hershey, Nestle, Danone, Abbott, Greenleaf Foods, Beyond Meat and others.
Jean Drouin, MD
Health Insights & Analytics
CEO and Founder of Clarify Health Solutions. Previously led McKinsey's Healthcare Digital and IT practice. Built and served as founding Head of McKinsey Advanced Healthcare Analytics (MAHA).